脳深部刺激装置:医療機器パイプライン分析2017

◆英語タイトル:Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017
◆発行会社/調査会社:GlobalData
◆商品コード:GDME0437EPD
◆発行日:2017年9月8日
◆調査対象地域:グローバル
◆産業分野:医療機器
◆ページ数:119
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,356,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[脳深部刺激装置:医療機器パイプライン分析2017]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Deep Brain Stimulators – Medical Devices Pipeline Assessment, 2017
Summary

GlobalData’s Medical Devices sector report, “Deep Brain Stimulators – Medical Devices Pipeline Assessment, 2017″ provides an overview of Deep Brain Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Deep Brain Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Deep Brain Stimulators under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Deep Brain Stimulators and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Deep Brain Stimulators under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

*** レポート目次(コンテンツ)***

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 9
2.1 Deep Brain Stimulators Overview 9
3 Products under Development 10
3.1 Deep Brain Stimulators – Pipeline Products by Stage of Development 10
3.2 Deep Brain Stimulators – Pipeline Products by Territory 11
3.3 Deep Brain Stimulators – Pipeline Products by Regulatory Path 12
3.4 Deep Brain Stimulators – Pipeline Products by Estimated Approval Date 13
3.5 Deep Brain Stimulators – Ongoing Clinical Trials 14
4 Deep Brain Stimulators – Pipeline Products under Development by Companies 15
4.1 Deep Brain Stimulators Companies – Pipeline Products by Stage of Development 15
4.2 Deep Brain Stimulators – Pipeline Products by Stage of Development 17
5 Deep Brain Stimulators Companies and Product Overview 19
5.1 Adaptive Neuromodulation GmbH Company Overview 19
5.1.1 Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 19
5.2 Aleva Neurotherapeutics SA Company Overview 20
5.2.1 Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Boston Scientific Corp Company Overview 22
5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 Brainsway Ltd Company Overview 29
5.4.1 Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
5.5 Cerene Biomedics, Inc. Company Overview 30
5.5.1 Cerene Biomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.6 Cerevast Therapeutics Inc Company Overview 31
5.6.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.7 Children’s Hospital Boston Company Overview 32
5.7.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 32
5.8 Cleveland Medical Devices Inc Company Overview 33
5.8.1 Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 Clinatec Company Overview 34
5.9.1 Clinatec Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 Deep Brain Innovations, LLC Company Overview 35
5.10.1 Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
5.11 Duke University Company Overview 40
5.11.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 40
5.12 Functional Neuromodulation Inc. Company Overview 41
5.12.1 Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.13 Integer Holdings Corp Company Overview 44
5.13.1 Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 44
5.14 Iowa State University Company Overview 45
5.14.1 Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 45
5.15 Massachusetts General Hospital Company Overview 46
5.15.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 46
5.16 Massachusetts Institute of Technology Company Overview 48
5.16.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 48
5.17 Mayo Clinic US Company Overview 49
5.17.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 49
5.18 Medtronic plc Company Overview 50
5.18.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 50
5.19 National Cheng-Kung University Hospital Company Overview 55
5.19.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 55
5.20 NeuroPro Technologies Inc Company Overview 56
5.20.1 NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 56
5.21 Neurosigma Inc Company Overview 57
5.21.1 Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.22 Newronika s.r.l. Company Overview 59
5.22.1 Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 59
5.23 Nexeon MedSystems Inc Company Overview 60
5.23.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.24 Rio Grande Neurosciences, Inc. Company Overview 61
5.24.1 Rio Grande Neurosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.25 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 62
5.25.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 62
5.26 St. Jude Medical LLC Company Overview 64
5.26.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 64
5.27 SUNY Downstate Medical Center Company Overview 68
5.27.1 SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 68
5.28 University of California Los Angeles Company Overview 69
5.28.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 69
5.29 University of Central Florida Company Overview 71
5.29.1 University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 71
5.30 University of Illinois Company Overview 72
5.30.1 University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 72
5.31 University of Michigan Company Overview 73
5.31.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 73
5.32 University of Milan Company Overview 74
5.32.1 University of Milan Pipeline Products & Ongoing Clinical Trials Overview 74
5.33 University of Oxford Company Overview 75
5.33.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 75
5.34 University of Rochester Company Overview 76
5.34.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 76
5.35 University of South Florida Company Overview 77
5.35.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 77
5.36 University of Utah Company Overview 80
5.36.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 80
5.37 Wedge Therapeutics Company Overview 82
5.37.1 Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 82
6 Deep Brain Stimulators- Recent Developments 83
6.1 Aug 22, 2017: Brainsway Reports Continued Successful Implementation of its New Business Model in Second Quarter of 2017 83
6.2 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 83
6.3 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 86
6.4 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 87
6.5 Jun 12, 2017: Brainsway Announces Positive Final Results of its Deep-TMS Multicenter Study in Obsessive Compulsive Disorder (OCD) Patients 89
6.6 Jun 06, 2017: Boston Scientific Receives CE Mark for Vercise Gevia Deep Brain Stimulation System 90
6.7 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 91
6.8 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 94
6.9 Apr 03, 2017: Yaacov Michlin Leads Brainsway to its Next Growth Phase and Accelerates the Mental Health Industry 95
6.10 Apr 03, 2017: Sheppard Pratt Health System Appoints New Chief Operating Officer 96
6.11 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 96
6.12 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 99
6.13 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 100
6.14 Jan 11, 2017: Great Lakes NeuroTechnologies Awarded Deep Brain Stimulation Programming Patent 101
6.15 Jan 10, 2017: Brainsway Appoints Yaacov Michlin as CEO 102
6.16 Nov 28, 2016: Brainsway Reports Continued Financial Growth for Q3 of 2016 102
6.17 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 103
6.18 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 105
6.19 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 106
6.20 Nov 01, 2016: Sheppard Pratt Health System Appoints New Chief Financial Officer 107
6.21 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 107
6.22 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 109
6.23 Oct 13, 2016: Baylor College of Medicine researcher and collaborators awarded grant through NIH BRAIN Initiative 110
6.24 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 112
6.25 Oct 07, 2016: Directional deep brain stimulation for movement disorders now being used 113
6.26 Oct 06, 2016: St. Jude Medical Announces U.S. Launch and First Implant of New Deep Brain Stimulation System and Directional Lead for Patients Suffering from Movement Disorders 113
6.27 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 114
7 Appendix 116
7.1 Methodology 116
7.2 About GlobalData 119
7.3 Contact Us 119
7.4 Disclaimer 119

1.1 List of Tables
Table 1: Deep Brain Stimulators - Pipeline Products by Stage of Development 10
Table 2: Deep Brain Stimulators - Pipeline Products by Territory 11
Table 3: Deep Brain Stimulators - Pipeline Products by Regulatory Path 12
Table 4: Deep Brain Stimulators - Pipeline Products by Estimated Approval Date 13
Table 5: Deep Brain Stimulators - Ongoing Clinical Trials 14
Table 6: Deep Brain Stimulators Companies - Pipeline Products by Stage of Development 15
Table 7: Deep Brain Stimulators - Pipeline Products by Stage of Development 17
Table 8: Adaptive Neuromodulation GmbH Pipeline Products & Ongoing Clinical Trials Overview 19
Table 9: CR-Capable Implant - Product Status 19
Table 10: CR-Capable Implant - Product Description 19
Table 11: Aleva Neurotherapeutics SA Pipeline Products & Ongoing Clinical Trials Overview 20
Table 12: directSTIM - Product Status 20
Table 13: directSTIM - Product Description 20
Table 14: spiderSTIM - Product Status 21
Table 15: spiderSTIM - Product Description 21
Table 16: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 22
Table 17: Cartesia Directional Lead - Product Status 22
Table 18: Cartesia Directional Lead - Product Description 23
Table 19: Enspire DBS Therapy System - Stroke - Product Status 23
Table 20: Enspire DBS Therapy System - Stroke - Product Description 23
Table 21: Enspire DBS Therapy System - Traumatic Brain Injury - Product Status 23
Table 22: Enspire DBS Therapy System - Traumatic Brain Injury - Product Description 24
Table 23: Vercise Deep Brain Stimulation System - Parkinson's Disease - Product Status 24
Table 24: Vercise Deep Brain Stimulation System - Parkinson's Disease - Product Description 24
Table 25: Vercise Primary Cell Deep Brain Stimulation System - Product Status 25
Table 26: Vercise Primary Cell Deep Brain Stimulation System - Product Description 25
Table 27: Boston Scientific Corp - Ongoing Clinical Trials Overview 26
Table 28: Vercise Deep Brain Stimulation System - Parkinson's Disease - Closed Loop Programming Evaluation Using External Responses for Deep Brain Stimulation: CLOVER 27
Table 29: Vercise Deep Brain Stimulation System - Parkinson's Disease - Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation 27
Table 30: Vercise Deep Brain Stimulation System - Parkinson's Disease - Implantable Neurostimulator for the Treatment of Parkinson's Disease 27
Table 31: Vercise Deep Brain Stimulation System - Parkinson's Disease - Kombinierte Tiefe Hirnstimulation Des Nucleus Subthalamicus Und Nucleus Basalis Meynert Zur Behandlung Der Parkinson-Krankheit Mit Demenz 28
Table 32: Vercise Deep Brain Stimulation System - Parkinson's Disease - Registry of Deep Brain Stimulation with the VERCISE System: Vercise DBS Registry 28
Table 33: Brainsway Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
Table 34: H7-Deep-TMS System - Obsessive Compulsive Disorder - Product Status 29
Table 35: H7-Deep-TMS System - Obsessive Compulsive Disorder - Product Description 29
Table 36: Cerene Biomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
Table 37: Implantable Cooling Therapy Device - Product Status 30
Table 38: Implantable Cooling Therapy Device - Product Description 30
Table 39: Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 40: Neurosonx SR - Home Version - Product Status 31
Table 41: Neurosonx SR - Home Version - Product Description 31
Table 42: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 32
Table 43: rTMS H-Coil - Product Status 32
Table 44: rTMS H-Coil - Product Description 32
Table 45: Cleveland Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 46: ParkinTune - Product Status 33
Table 47: ParkinTune - Product Description 33
Table 48: Clinatec Pipeline Products & Ongoing Clinical Trials Overview 34
Table 49: Intracranial Deep Brain Stimulation Device - Product Status 34
Table 50: Intracranial Deep Brain Stimulation Device - Product Description 34
Table 51: Deep Brain Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview 35
Table 52: TOPS Device - Alzheimer's disease - Product Status 35
Table 53: TOPS Device - Alzheimer's disease - Product Description 35
Table 54: TOPS Device - Depression - Product Status 36
Table 55: TOPS Device - Depression - Product Description 36
Table 56: TOPS Device - Epilepsy - Product Status 36
Table 57: TOPS Device - Epilepsy - Product Description 37
Table 58: TOPS Device - Obesity - Product Status 37
Table 59: TOPS Device - Obesity - Product Description 37
Table 60: TOPS Device - Obsessive-Compulsive Disorder - Product Status 38
Table 61: TOPS Device - Obsessive-Compulsive Disorder - Product Description 38
Table 62: TOPS Device - Parkinson's disease - Product Status 38
Table 63: TOPS Device - Parkinson's disease - Product Description 39
Table 64: Duke University Pipeline Products & Ongoing Clinical Trials Overview 40
Table 65: DBS Electrode - Product Status 40
Table 66: DBS Electrode - Product Description 40
Table 67: Functional Neuromodulation Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 68: Deep Brain Stimulation - Mild Alzheimer's Disease - Product Status 41
Table 69: Deep Brain Stimulation - Mild Alzheimer's Disease - Product Description 41
Table 70: Functional Neuromodulation Inc. - Ongoing Clinical Trials Overview 42
Table 71: Deep Brain Stimulation - Mild Alzheimer's Disease - A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients with Mild Probable Alzheimer's Disease 43
Table 72: Integer Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 44
Table 73: Disposable Surgical Electrode - Product Status 44
Table 74: Disposable Surgical Electrode - Product Description 44
Table 75: Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 45
Table 76: Triple Halo Coil - Product Status 45
Table 77: Triple Halo Coil - Product Description 45
Table 78: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 46
Table 79: Deep Brain Stimulation Device - Product Status 46
Table 80: Deep Brain Stimulation Device - Product Description 46
Table 81: Deep Brain Stimulation System - Product Status 47
Table 82: Deep Brain Stimulation System - Product Description 47
Table 83: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 48
Table 84: Implantable Micro - Cannula Device - Product Status 48
Table 85: Implantable Micro - Cannula Device - Product Description 48
Table 86: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 49
Table 87: Sensor System - DBS - Product Status 49
Table 88: Sensor System - DBS - Product Description 49
Table 89: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 50
Table 90: Activa SC Neurostimulator - Epilepsy - Product Status 50
Table 91: Activa SC Neurostimulator - Epilepsy - Product Description 50
Table 92: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Product Status 51
Table 93: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Product Description 51
Table 94: Reclaim Deep Brain Stimulation System - Depression - Product Status 51
Table 95: Reclaim Deep Brain Stimulation System - Depression - Product Description 52
Table 96: Sapiens DBS Field Steering System - Product Status 52
Table 97: Sapiens DBS Field Steering System - Product Description 52
Table 98: Medtronic plc - Ongoing Clinical Trials Overview 53
Table 99: Intercept Patient Programmer For Activa PC - Refractory Epilepsy - Medtronic Registry for Epilepsy: MORE 54
Table 100: National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 55
Table 101: Responsive Epilepsy Control System-On-Chip - Product Status 55
Table 102: Responsive Epilepsy Control System-On-Chip - Product Description 55
Table 103: NeuroPro Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 56
Table 104: Deep Brain Stimulation - Product Status 56
Table 105: Deep Brain Stimulation - Product Description 56
Table 106: Neurosigma Inc Pipeline Products & Ongoing Clinical Trials Overview 57
Table 107: Deep Brain Stimulation System - Cachexia - Product Status 57
Table 108: Deep Brain Stimulation System - Cachexia - Product Description 57
Table 109: Deep Brain Stimulation System - Obesity - Product Status 58
Table 110: Deep Brain Stimulation System - Obesity - Product Description 58
Table 111: Newronika s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 59
Table 112: Implantable Deep Brain Stimulation Device - Product Status 59
Table 113: Implantable Deep Brain Stimulation Device - Product Description 59
Table 114: Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 115: Synapse - Product Status 60
Table 116: Synapse - Product Description 60
Table 117: Rio Grande Neurosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 118: DSF-rTMS - Product Status 61
Table 119: DSF-rTMS - Product Description 61
Table 120: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 62
Table 121: Implantable Electrode - Epilepsy Surgery - Product Status 62
Table 122: Implantable Electrode - Epilepsy Surgery - Product Description 62
Table 123: Indigenous Deep Brain Stimulation Device - Product Status 63
Table 124: Indigenous Deep Brain Stimulation Device - Product Description 63
Table 125: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 64
Table 126: Libra Deep Brain Stimulation System - Depression - Product Status 64
Table 127: Libra Deep Brain Stimulation System - Depression - Product Description 64
Table 128: Next Generation Implantable DBS System - Primary Cell - Product Status 65
Table 129: Next Generation Implantable DBS System - Primary Cell - Product Description 65
Table 130: St. Jude Medical LLC - Ongoing Clinical Trials Overview 66
Table 131: Libra Deep Brain Stimulation System - Depression - A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression 67
Table 132: Libra Deep Brain Stimulation System - Depression - Deep Brain Stimulation for Treatment-Resistant Depression 67
Table 133: SUNY Downstate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 68
Table 134: Low-Frequency Sine Wave Neurostimulation Therapy Device - Product Status 68
Table 135: Low-Frequency Sine Wave Neurostimulation Therapy Device - Product Description 68
Table 136: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 69
Table 137: Implantable Ultrasound Neuromodulation Device - Product Status 69
Table 138: Implantable Ultrasound Neuromodulation Device - Product Description 69
Table 139: Wireless Deep Brain Stimulating System - Product Status 70
Table 140: Wireless Deep Brain Stimulating System - Product Description 70
Table 141: University of Central Florida Pipeline Products & Ongoing Clinical Trials Overview 71
Table 142: Deep Brain Stimulation System - Product Status 71
Table 143: Deep Brain Stimulation System - Product Description 71
Table 144: University of Illinois Pipeline Products & Ongoing Clinical Trials Overview 72
Table 145: Wireless Deep Brain Stimulation System - Essential Tremor - Product Status 72
Table 146: Wireless Deep Brain Stimulation System - Essential Tremor - Product Description 72
Table 147: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 73
Table 148: Deep Brain Stimulation System - Product Status 73
Table 149: Deep Brain Stimulation System - Product Description 73
Table 150: University of Milan Pipeline Products & Ongoing Clinical Trials Overview 74
Table 151: Implantable Brain Pacemaker - Product Status 74
Table 152: Implantable Brain Pacemaker - Product Description 74
Table 153: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 75
Table 154: Adaptive Deep Brain Stimulation System - Product Status 75
Table 155: Adaptive Deep Brain Stimulation System - Product Description 75
Table 156: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 76
Table 157: Deep Brain Magnetic Stimulator - Product Status 76
Table 158: Deep Brain Magnetic Stimulator - Product Description 76
Table 159: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 77
Table 160: Deep Brain Stimulator - Product Status 77
Table 161: Deep Brain Stimulator - Product Description 77
Table 162: University of South Florida - Ongoing Clinical Trials Overview 78
Table 163: Deep Brain Stimulator - Subthalamic Nucleus (STN) and Globus Pallidus Internus (GPi) Deep Brain Stimulation (DBS) in Patients with Primary Dystonia 79
Table 164: University of Utah Pipeline Products & Ongoing Clinical Trials Overview 80
Table 165: DBS10k - Product Status 80
Table 166: DBS10k - Product Description 80
Table 167: Neural Recording Array - Product Status 81
Table 168: Neural Recording Array - Product Description 81
Table 169: Wedge Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 82
Table 170: SONS System - Product Status 82
Table 171: SONS System - Product Description 82
Table 172: Glossary 118

1.2 List of Figures
Figure 1: Deep Brain Stimulators - Pipeline Products by Stage of Development 10
Figure 2: Deep Brain Stimulators - Pipeline Products by Territory 11
Figure 3: Deep Brain Stimulators - Pipeline Products by Regulatory Path 12
Figure 4: Deep Brain Stimulators - Pipeline Products by Estimated Approval Date 13
Figure 5: Deep Brain Stimulators - Ongoing Clinical Trials 14

*** 掲載企業 ***

Adaptive Neuromodulation GmbH
Aleva Neurotherapeutics SA
Boston Scientific Corp
Brainsway Ltd
Cerene Biomedics, Inc.
Cerevast Therapeutics Inc
Children's Hospital Boston
Cleveland Medical Devices Inc
Clinatec
Deep Brain Innovations, LLC
Duke University
Functional Neuromodulation Inc.
Integer Holdings Corp
Iowa State University
Massachusetts General Hospital
Massachusetts Institute of Technology
Mayo Clinic US
Medtronic plc
National Cheng-Kung University Hospital
NeuroPro Technologies Inc
Neurosigma Inc
Newronika s.r.l.
Nexeon MedSystems Inc
Rio Grande Neurosciences, Inc.
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
SUNY Downstate Medical Center
University of California Los Angeles
University of Central Florida
University of Illinois
University of Michigan
University of Milan
University of Oxford
University of Rochester
University of South Florida
University of Utah
Wedge Therapeutics

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDME0437EPD )"脳深部刺激装置:医療機器パイプライン分析2017" (英文:Deep Brain Stimulators - Medical Devices Pipeline Assessment, 2017)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。